Safety of trastuzumab emtansine (T-DM1) in HER2-positive advanced breast cancer (BC) patients (pts): Primary results from KAMILLA study cohort 1.-MedSci.cn

Safety of trastuzumab emtansine (T-DM1) in HER2-positive advanced breast cancer (BC) patients (pts): Primary results from KAMILLA study cohort 1.

Barrios, CH; Wuerstlein, R; Anton, A; Delaloge, S; Montemurro, F; Bonneterre, J; Quenel-Tueux, N; Linn, SC; Button, P; Lindegger, N; Ellis, PA

JOURNAL OF CLINICAL ONCOLOGY, 2017; 35 ( ):

科室
- - 订阅+
  - 更多科室
工具
服务